SGS Pharma supports pharmaceutical, biopharmaceutical and CDMO organisations across the full product lifecycle, from early R&D and preclinical development through clinical trials, commercial manufacturing and post-market assurance. Our services span pharma CRO clinical research and GMP / GLP drug development and testing. SGS Pharma operates through two core divisions. Clinical Research delivers early-phase CRO services including clinical pharmacology, Phase I–IIa trials, biometrics, data management, biostatistics, medical writing, pharmacovigilance and regulatory support. Drug Development provides GMP and GLP pharmaceutical and biopharmaceutical testing for small molecules, biologics, biosimilars, cell and gene therapies, ATMPs, Read more